表紙
市場調查報告書

圍繞新型冠狀病毒感染疾病(COVID-19):新的疾病的形勢分析: 2020年6月

Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020

出版商 GlobalData 商品編碼 951723
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
圍繞新型冠狀病毒感染疾病(COVID-19):新的疾病的形勢分析: 2020年6月 Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020
出版日期: 2020年07月30日內容資訊: 英文 48 Pages
簡介

新型冠狀病毒感染疾病(COVID-19)的流行病學研究急速前進,許多企業開始這個領域的投資。由於沒有有成效的治療方法選項 ,沒有預防感染疾病的疫苗,有效的介入方法的開發開始競爭,從製藥公司和生物科技企業到學術機構,政府機關,各種組織肩負其作用。

本報告提供COVID-19治療藥和疫苗的開發平台和臨床試驗分析,開發平台臨床試驗概要,協定和社群媒體趨勢等資訊。

目錄

目錄

第1章 摘要整理

第2章 流行病學

  • 流行病學:2020年3月25日時的概述
  • 流行病學:至2020年3月25日的軌跡
  • 最受影響的前3名國家的流行病學指標:至2020年3月25日的中國的軌跡
  • 最受影響的前3名國家的流行病學指標:至2020年3月25日的義大利的軌跡
  • 最受影響的前3名國家的流行病學指標:至2020年3月25日的美國的軌跡
  • 流行病學預測: 美國

第3章 開發平台概要

  • 治療藥:各階段的明細
  • 治療藥:各分子類型的明細
  • 治療藥:開發商的各種類的明細
  • 治療藥:臨床階段的候補(I-III階段)
  • 治療藥:前臨床階段的候補
  • 治療藥:現在可以利用的資料
  • 疫苗:各階段的明細
  • 疫苗:開發商的各種類的明細
  • 疫苗:臨床階段和前臨床階段的候補

第4章 開發平台概要

  • 治療藥:各階段的明細
  • 治療藥:各分子類型的明細
  • 治療藥:開發商的各種類的明細
  • 治療藥:臨床階段的候補(I-III階段)
  • 治療藥:前臨床階段的候補
  • 治療藥:現在可以利用的資料
  • 疫苗:各階段的明細
  • 疫苗:開發商的各種類的明細
  • 疫苗:臨床階段和前臨床階段的候補

第5章 臨床試驗

  • 臨床試驗:各階段的明細
  • 治療藥和疫苗的臨床試驗
  • 臨床試驗:各地區的概要
  • 治療藥的臨床試驗:主要的臨床試驗贊助者
  • 臨床試驗:產業的主要的臨床試驗贊助者
  • 臨床試驗設計趨勢

第6章 協定趨勢

第7章 社群媒體趨勢

  • Twitter的主要的投稿者
  • #Covid19 #Coronavirus #Patients #Flattenthecurve等熱門趨勢的tsuito

第8章 主要調查結果

第9章 附錄

  • 出處
  • 調查手法
  • 關於筆者

第10章 關於GlobalData

  • 諮詢方式
目錄
Product Code: GDHCHT113

The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.

Scope

  • Global epidemiology metrics and trends
  • Snapshot of epidemiological trends to date in the top three most-affected countries
  • An overview of the pipeline for antivirals and vaccines
  • Summary of available efficacy data
  • An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
  • Highlights in deal-making trends, particularly public-private partnerships
  • Spotlight on social media coverage

Reasons to Buy

  • Understand the global epidemiology of COVID-19
  • Obtain a snapshot of epidemiological trends to date in the top three most-affected countries
  • Access an overview of the pipeline for therapeutics and vaccines
  • Stay up to date on available efficacy data for pipeline-stage products
  • View the clinical trials landscape by across key attributes
  • Get up to speed on highlights in deal-making trends, particularly public-private partnerships
  • Monitor top trends in social media coverage

Table of Contents

Table of Contents

1 Executive Summary

  • 1.1 Report Scope
  • 1.2 Navigate the COVID-19 Outbreak with GlobalData Pharma's COVID-19 Dashboard
  • 1.3 Monitor the COVID-19 Outbreak with GlobalData Epidemiology Indicators

2 Epidemiology

  • 2.1 Epidemiology: Snapshot as of March 25, 2020
  • 2.2 Epidemiology: Disease Trajectory as of March 25, 2020
  • 2.3 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in China as of March 25, 2020
  • 2.4 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in Italy as of March 25, 2020
  • 2.5 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in the US as of March 25, 2020
  • 2.6 Epidemiology Forecast: United States

3 Pipeline Overview

  • 3.1 Pipeline Therapeutics: Breakdown by Phase
  • 3.2 Pipeline Therapeutics: Breakdown by Molecule Type
  • 3.3 Pipeline Therapeutics: Breakdown by Type of Developer
  • 3.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)
  • 3.5 Pipeline Therapeutics: Preclinical-Stage Candidates
  • 3.6 Pipeline Therapeutics: Currently Available Data
  • 3.7 Pipeline Vaccines: Breakdown by Phase
  • 3.8 Pipeline Vaccines: Breakdown by Developer Type
  • 3.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

4 Pipeline Overview

  • 4.1 Pipeline Therapeutics: Breakdown by Phase
  • 4.2 Pipeline Therapeutics: Breakdown by Molecule Type
  • 4.3 Pipeline Therapeutics: Breakdown by Type of Developer
  • 4.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)
  • 4.5 Pipeline Therapeutics: Preclinical-Stage Candidates
  • 4.6 Pipeline Therapeutics: Currently Available Data
  • 4.7 Pipeline Vaccines: Breakdown by Phase
  • 4.8 Pipeline Vaccines: Breakdown by Developer Type
  • 4.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

5 Clinical Trials

  • 5.1 Clinical Trials: Breakdown by Phase
  • 5.2 Clinical Trials for Therapeutics and Vaccines
  • 5.3 Clinical Trials: Overview by Region
  • 5.4 Clinical Trials for Therapeutics: Leading Sponsors
  • 5.5 Clinical Trials: Leading Industry Sponsors
  • 5.6 Trends in Trial Design

6 Deal-making Trends

  • 6.1 Deal-making Trends

7 Social Media Trends

  • 7.1 Key Twitter Chatter
  • 7.2 Top Trending Tweets include #Covid19 #Coronavirus #Patients #Flattenthecurve

8 Key Findings

  • 8.1 Key Findings

9 Appendix

  • 9.1 Sources
  • 9.2 Methodology
  • 9.3 About the Authors

10 About GlobalData

  • 10.1 Contact Us